Login / Signup

Frequent and Yet Unreported GNAQ and GNA11 Mutations are Found in Uveal Melanomas.

Bjoern SchneiderKatrin RiedelAndrey ZhivovMaja HuehnsHeike ZettlRudolf F GuthoffAnselm JünemannAndreas ErbersdoblerAnnette Zimpfer
Published in: Pathology oncology research : POR (2017)
Malignant melanoma of the uvea is the most common primary malignant tumor in the eye. We aimed to analyze GNAQ and GNA11 mutations in uveal melanomas using formalin-fixed, paraffin-embedded material and correlate the results with clinicopathological parameters. Tumor tissue was microdissected followed by amplification of GNAQ exon 4 and 5, GNA11 exon 4 and 5, and finally analyzed by Sanger sequencing. A total of 64.4 GNA11/GNAQ mutations, including ten yet unreported, were found. Two cases showed multiple mutations. Overall survival was significantly shorter in the uveal melanoma cohort with GNAQ exon 5 mutation. In concordance with previous studies, high frequencies of mutations in GNAQ or GNA11 were detected. Interestingly, in about 20% of UM, not yet reported mutations in GNAQ or GNA11 were seen. Rarely, uveal melanoma may harbor double mutations in GNAQ and/or GNA11. Recent data imply, that implementation of GNAQ/GNA11 mutation analysis in routine diagnostic procedures might be helpful for future therapeutic decisions.
Keyphrases
  • primary care
  • healthcare
  • quality improvement